FPR2 and Alzheimer disease: Next we examined the possible contribution of the endogenous ANXA1 and its receptor FPR2 on the BBB disruption in AD utilizing Aβ42‐treated bEnd.3 cells and the brain capillaries of 9‐ to 10‐month‐old 5XFAD mice.